The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between chemotherapy use and clinical outcomes in young BRCA carriers with T1N0 breast cancer: Results from an international cohort study.
 
Filipa Lynce
Leadership - Alliance Foundation Trials
Consulting or Advisory Role - AmerisourceBergen; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Pfizer; Prime Education
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Gilead Sciences; IDEAYA Biosciences; Incyte; Merck; Zentalis
 
Eva Blondeaux
No Relationships to Disclose
 
Virginia Delucchi
No Relationships to Disclose
 
Hee Jeong Kim
Honoraria - Alvogen Korea; Takeda
 
Rinat Bernstein-Molho
No Relationships to Disclose
 
Sabine Linn
Consulting or Advisory Role - AstraZeneca/Merck (Inst); Daiichi Sankyo (Inst)
Research Funding - Agendia (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eurocept Pharmaceuticals (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - PCT/EP2022/073958 Method for assessing homologous recombination deficiency in ovarian cancer cells (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH (Inst)
 
Florence Coussy
No Relationships to Disclose
 
Antonio Di Meglio
Expert Testimony - Kephren; techspert.io
 
Kelly-Anne Phillips
Research Funding - AstraZeneca (Inst)
 
Ava Kwong
Honoraria - AstraZeneca; AstraZeneca Hong Kong Limited; Pfizer; Stryker
Research Funding - AstraZeneca; Merck Sharp & Dohme Asia) Limited; Roche Hong Kong Limited
 
Hans Wildiers
Consulting or Advisory Role - Agendia (Inst); Astrazeneca (Inst); Augustine Therapeutics (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Immutep (Inst); Lilly (Inst); MediMix bv (Inst); Menarini (Inst); Novartis (Inst); NV Hict (Inst); Pfizer (Inst); PSI (Inst); Roche (Inst); Seagen (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly (Inst); Gilead Sciences (Inst)
 
Elisa Agostinetto
Honoraria - Abscint (Inst); AstraZeneca; Lilly
Consulting or Advisory Role - AstraZeneca (Inst)
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Abscint; AstraZeneca; AstraZeneca; Daiichi Sankyo Europe GmbH; Genetic Spa; Novartis
 
Robert Fruscio
No Relationships to Disclose
 
Alberta Ferrari
Consulting or Advisory Role - AstraZeneca; MSD
 
Laura De Marchis
No Relationships to Disclose
 
Carmen Criscitiello
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Katarzyna Pogoda
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Novartis; Sandoz
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly Poland; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Meredith Regan
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Bristol-Myers Squibb; Tersera; Tolmar
Research Funding - Bayer (Inst); bioTheranostics (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Ann Partridge
Patents, Royalties, Other Intellectual Property - Wolters Kluwer- royalties for authorship of UpToDate
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Knight Therapeutics; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche